Ignite Creation Date:
2024-05-06 @ 6:58 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05845671
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2023-04-25
Brief Title:
Amivantamab With Tyrosine Kinase Inhibitors TKI for Advanced NSCLC With ALK ROS1 or RET Alterations
Sponsor:
University of Colorado Denver
Organization:
University of Colorado Denver
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-11
Start Date Type:
ACTUAL
Primary Completion Date:
2027-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-04-25
First Submit QC Date:
April 25 2023
Study First Post Date:
2023-05-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-15
Last Update Post Date:
2024-06-20
Last Update Post Date Type:
ACTUAL